missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Thermo Scientific™ HA Synthetic Peptide
HA Synthetic peptide 26184 from Thermo Scientific™ specifically detects HA in samples, and it is validated for Control
Brand: Thermo Scientific™ 26184
This item is not returnable.
View return policy
Description
HA Synthetic peptide 26184 from Thermo Scientific™ specifically detects HA in samples, and it is validated for Control
The HA peptide, NH2-YPYDVPDYA-COOH, is a synthetic peptide used to competitively elute fusion proteins containing the influenza hemagglutinin (HA) tag bound to immobilized anti-HA affinity resins.Formulation: 5 mg purified Peptide (1mg/mL) no preservative;
26184 detects HA in samples. 26184 has been successfully used in Control procedures.
Specifications
Recombinant | |
Store at 4°C. | |
Immunoprecipitation | |
5 mg |
Safety and Handling
Product Identifier
Signal Word
Hazard Category
Hazard Statement
Precautionary Statement
Supplemental information
- Isopropanol
Signal Word
- Danger
Hazard Category
- Serious eye damage/eye irritation Category 2
- Flammable liquid Category 2
- Specific target organ toxicity Category 3
Hazard Statement
- H225-Highly flammable liquid and vapour.
- H319-Causes serious eye irritation.
- H336-May cause drowsiness or dizziness.
Precautionary Statement
- P210-Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking.
- P240-Ground/bond container and receiving equipment.
- P261-Avoid breathing dust/fume/gas/mist/vapours/spray.
- P280-Wear protective gloves/protective clothing/eye protection/face protection.
- P305+P351+P338-IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
Supplemental information
- MIXTURE LIST-Contains : isopropanol
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only. Not for use in diagnostic procedures.
Spot an opportunity for improvement?Share a Content Correction